國立虎尾科技大學 |

Advances in Microbiology, Infectious Diseases and Public Health = Volume 16 /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Advances in Microbiology, Infectious Diseases and Public Health/ edited by Gianfranco Donelli.
Reminder of title:	Volume 16 /
other author:	Donelli, Gianfranco.
Description:	VI, 141 p. 52 illus., 20 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Medical microbiology. -
Online resource:	https://doi.org/10.1007/978-3-031-01995-1
ISBN:	9783031019951

Advances in Microbiology, Infectious Diseases and Public Health = Volume 16 /
Advances in Microbiology, Infectious Diseases and Public HealthVolume 16 /[electronic resource] :edited by Gianfranco Donelli. - 1st ed. 2022. - VI, 141 p. 52 illus., 20 illus. in color.online resource. - Advances in Microbiology, Infectious Diseases and Public Health,13692365-2683 ;. - Advances in Microbiology, Infectious Diseases and Public Health,901.

Personalized nutrition for microbiota correction and metabolism restore in type 2 diabetes mellitus patients -- Beyond Bone: Infectious diseases and immunity in parathyroid disorders -- In vitro antimicrobial susceptibility testing of biofilm-growing bacteria: current and emerging methods -- Antibiofilm Efficacy of Polihexanide, Octenidine and Sodium Hypochlorite/Hypochlorous Acid Based Wound Irrigation Solutions against Staphylococcus aureus, Pseudomonas aeruginosa and a Multispecies Biofilm -- Molecular Characterization of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Isolates Collected from Inanimate Hospital Environments in Addis Ababa, Ethiopia -- Distribution and Antibiotics Resistance Pattern of Community-Acquired Methicillin-Resistance Staphylococcus aureus in Southwestern Nigeria -- Ultrastructural and Immunohistochemical Diagnosis of a Neonatal Herpes Simplex Virus Infection Presenting as Fulminant Hepatitis: A Case Report -- Antimicrobial Activity of Xibornol and a Xibornol-Based Formulation Against Gram-Positive Pathogens of the Respiratory Tract -- Achille Sclavo (1861-1930) and his innovative contributions to Italian preventive medicine and healthcare policy -- The magnitude of Carbapenemase and ESBL producing Enterobacteriaceae isolates from patients with Urinary Tract Infections at Tikur Anbessa Specialized Teaching Hospital, Addis Ababa, Ethiopia.

This book series focuses on current progress in the broad field of medical microbiology, and covers both basic and applied topics related to the study of microbes, their interactions with human and animals, and emerging issues relevant for public health. Original research and review articles present and discuss multidisciplinary findings and developments on various aspects of microbiology, infectious diseases, and their diagnosis, treatment and prevention. The book series publishes review and original research contributions, short reports as well as guest edited thematic book volumes. All contributions will be published online first and collected in book volumes. There are no publication costs. Advances in Microbiology, Infectious Diseases and Public Health is a subseries of Advances in Experimental Medicine and Biology, which has been publishing significant contributions in the field for over 30 years and is indexed in Medline, Scopus, EMBASE, BIOSIS, Biological Abstracts, CSA, Biological Sciences and Living Resources (ASFA-1), and Biological Sciences. 2020 Impact Factor: 2.622. 5 Year Impact Factor: 3.049; Cite Score: 3.9; Eigenfactor Score: 0.03583; Article Influence Score: 0.602.

ISBN: 9783031019951

Standard No.: 10.1007/978-3-031-01995-1doiSubjects--Topical Terms:

583124
Medical microbiology.

LC Class. No.: QR46

Dewey Class. No.: 616.9041

Advances in Microbiology, Infectious Diseases and Public Health = Volume 16 /
LDR:04101nam a22004095i 4500 001 1094649
003 DE-He213
005 20220504232108.0
007 cr nn 008mamaa
008 221228s2022 sz | s |||| 0|eng d
020 $a 9783031019951 $9 978-3-031-01995-1
024 7 $a 10.1007/978-3-031-01995-1 $2 doi
035 $a 978-3-031-01995-1
050 4 $a QR46
072 7 $a MMFM $2 bicssc
072 7 $a MED052000 $2 bisacsh
072 7 $a MKFM $2 thema
082 0 4 $a 616.9041 $2 23
245 1 0 $a Advances in Microbiology, Infectious Diseases and Public Health $h [electronic resource] : $b Volume 16 / $c edited by Gianfranco Donelli.
250 $a 1st ed. 2022.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a VI, 141 p. 52 illus., 20 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Advances in Microbiology, Infectious Diseases and Public Health, $x 2365-2683 ; $v 1369
505 0 $a Personalized nutrition for microbiota correction and metabolism restore in type 2 diabetes mellitus patients -- Beyond Bone: Infectious diseases and immunity in parathyroid disorders -- In vitro antimicrobial susceptibility testing of biofilm-growing bacteria: current and emerging methods -- Antibiofilm Efficacy of Polihexanide, Octenidine and Sodium Hypochlorite/Hypochlorous Acid Based Wound Irrigation Solutions against Staphylococcus aureus, Pseudomonas aeruginosa and a Multispecies Biofilm -- Molecular Characterization of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Isolates Collected from Inanimate Hospital Environments in Addis Ababa, Ethiopia -- Distribution and Antibiotics Resistance Pattern of Community-Acquired Methicillin-Resistance Staphylococcus aureus in Southwestern Nigeria -- Ultrastructural and Immunohistochemical Diagnosis of a Neonatal Herpes Simplex Virus Infection Presenting as Fulminant Hepatitis: A Case Report -- Antimicrobial Activity of Xibornol and a Xibornol-Based Formulation Against Gram-Positive Pathogens of the Respiratory Tract -- Achille Sclavo (1861-1930) and his innovative contributions to Italian preventive medicine and healthcare policy -- The magnitude of Carbapenemase and ESBL producing Enterobacteriaceae isolates from patients with Urinary Tract Infections at Tikur Anbessa Specialized Teaching Hospital, Addis Ababa, Ethiopia.
520 $a This book series focuses on current progress in the broad field of medical microbiology, and covers both basic and applied topics related to the study of microbes, their interactions with human and animals, and emerging issues relevant for public health. Original research and review articles present and discuss multidisciplinary findings and developments on various aspects of microbiology, infectious diseases, and their diagnosis, treatment and prevention. The book series publishes review and original research contributions, short reports as well as guest edited thematic book volumes. All contributions will be published online first and collected in book volumes. There are no publication costs. Advances in Microbiology, Infectious Diseases and Public Health is a subseries of Advances in Experimental Medicine and Biology, which has been publishing significant contributions in the field for over 30 years and is indexed in Medline, Scopus, EMBASE, BIOSIS, Biological Abstracts, CSA, Biological Sciences and Living Resources (ASFA-1), and Biological Sciences. 2020 Impact Factor: 2.622. 5 Year Impact Factor: 3.049; Cite Score: 3.9; Eigenfactor Score: 0.03583; Article Influence Score: 0.602.
650 0 $a Medical microbiology. $3 583124
650 0 $a Biofilms. $3 676933
650 0 $a Microbial populations. $3 1366747
650 0 $a Microbiology—Technique. $3 1390557
650 1 4 $a Medical Microbiology. $3 668401
650 2 4 $a Microbial Communities. $3 1366748
650 2 4 $a Microbiology Techniques. $3 1390558
700 1 $a Donelli, Gianfranco. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1063749
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783031019944
776 0 8 $i Printed edition: $z 9783031019968
776 0 8 $i Printed edition: $z 9783031019975
830 0 $a Advances in Microbiology, Infectious Diseases and Public Health, $x 2365-2675 ; $v 901 $3 1268224
856 4 0 $u https://doi.org/10.1007/978-3-031-01995-1
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)